Skip to main content
Log in

Abacavir/dolutegravir/lamivudine

Hypersensitivity reaction: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Chin BS, et al. Similar Durability of Two Single Tablet Regimens, Dolutegravir/Abacavir/Lamivudine and Elvitegravir/Cobicistat/Tenofovir/Emtricitabine: Single Center Experience. Journal of Korean Medical Science 35: No. 29, 27 Jul 2020. Available from: URL: http://doi.org/10.3346/jkms.2020.35.e235

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abacavir/dolutegravir/lamivudine. Reactions Weekly 1865, 19 (2021). https://doi.org/10.1007/s40278-021-99307-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-99307-5

Navigation